All News ATTANA AB Börse Stuttgart

Equities

SE0010547273

End-of-day quote Börse Stuttgart Other stock markets			5-day change	1st Jan Change
- ^EUR	-.--%		-.--%	-.--%

02/05	Attana AB Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
30/04	BioInvent Announces Evaluating Attana Technology	CI

All News

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Attana AB Reports Earnings Results for the First Quarter Ended March 31, 2024	03/05	CI
BioInvent evaluating Attana Technology	30/04	AQ
BioInvent Announces Evaluating Attana Technology	30/04	CI
Attana enters the third year of a five-year service and support contract with a leading health institute in the US	25/04	AQ
Attana AB Enters Third Year of A Five-Year Service and Support Contract with A Leading Health Institute in the US	25/04	CI
New paper using Attana tecnology to understand how viruses enter human cells	01/04	AQ
One of US leading health institutes has placed an order for an upgrade of an existing instrument, valued at $150k	05/03	AQ
Attana AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	23/02	CI
New paper using Attana Technology to study structures on surface in Ion Liquids demonstrating the effect of surface charges on interaction properties.	13/02	AQ
New publication using Attana technology towards environmentally friendly and financially viable methods to create functional materials	23/01	AQ
New article using Attana's technology from National University of Singapore: Immunity differences in vaccinated individuals according to age, gender, lifestyle and other diseases	20/12	AQ
Biosensors to characterize immune response to bacterial diseases	18/12	AQ
Attana and Linnaeus University have published the first part of the science behind immunity profiles	05/12	AQ
Attana Lands Order for Kinetic Interaction Analysis of Tissue in US	04/12	MT
Breakthrough order with new customer in the USA	04/12	AQ
Attana AB Receives Breakthrough Order with New Customer in the USA	04/12	CI
Strengthened collaboration with European biotech customer who extends their service and support agreement for another 12 months.	23/11	AQ
Customer Develops Therapeutic Antibodies Against Cancer and Uses Attana's Cell-Based Technology	23/11	CI
A new publication using Attana Technology from National University of Singapore examining the neutralization capacity of human IgG antibodies agsinst different mutations of the SARS-CoV-2	20/11	AQ
Robust QCM-Based Sensing and Assay Formats in Commercialized Systems	15/11	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News ATTANA AB Börse Stuttgart

Equities

SE0010547273

All News

Filters